Article may be outdated

This article is 6 days old. Some details may have changed since publication.

The Manila Times·4 min read·hard

23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer's Prevention Research

23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer's Prevention Research
✦AI Summary

23andMe Research Institute and Scripps Research have partnered to use genetic data to recruit participants for a new Alzheimer's prevention study called the Wellderly Brain Study. The trial aims to test whether digital lifestyle coaching can impact biological markers associated with Alzheimer's disease.

Why it matters

This partnership leverages large-scale genetic databases to advance precision medicine and preventative strategies for neurodegenerative diseases.

✦Dive DeeperCreate a free account to unlock

Partnership pairs 23andMe Research Institute's consented research community with novel Scripps Research-led Alzheimer's prevention study

PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute and Scripps Research, through its operating division the Scripps Research Translational Institute (SRTI), are partnering to bring genetics-based recruitment to Alzheimer's disease research. Under the partnership, 23andMe Research Institute will serve as the recruitment partner for the Wellderly Brain Study, which aims to determine whether lifestyle modification can shift disease-related biological pathways, providing a scalable, evidence-based model for early Alzheimer's prevention and monitoring.

"We’re thrilled to partner with the 23andMe Research Institute who are providing invaluable support to identify suitable participants,” said Eric Topol, M.D., Executive Vice-President of Scripps Research. "Our aspiration, which we believe will ultimately be achievable, is to prevent Alzheimer’s disease.”

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthsciencebusiness
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in